Sign in

NCT07365982Completed

Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia

THE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA

Source: ClinicalTrials.gov · Last updated 26 Jan 2026

Brief summary (registry, in English)

This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study employed a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements. Participants were recruited from a community mental health center and assigned to an intervention group or a control group. The intervention group participated in a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, while the control group continued to receive routine community mental health services. Knowledge about schizophrenia and hope levels were assessed using validated measurement tools.

Status (registry)
Completed
Study type
Interventional
Enrollment
44 (actual)
First submitted
9 Jan 2026
Start date
21 Apr 2025
Primary completion date
30 Jun 2025
Lead sponsor
Büşra Taşkıner
NCT number
NCT07365982

What you commit to

  • Study type: Interventional
  • Participants enrolled: 44
  • From 21 Apr 2025 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of dementia and/or other organic mental disorders
  • Discontinuation of intervention sessions or failure to complete assessment forms

Other

  • Presence of severe intellectual disability as documented in hospital records
  • Currently in an acute exacerbation phase

Who the study is looking for

  • Volunteered to participate in the study and provided informed consent
  • Aged between 18 and 65 years
  • Literate
  • Diagnosed with schizophrenia according to DSM-5 diagnostic criteria
  • In remission phase (not in an acute exacerbation period)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Zeytinburnu Community Mental Health Center (TRSM)
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.